The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...

Amgen's cholesterol-lowering antibody Repatha is being launched in Europe at well below the new drug's cost in the US, raising the chance that American payers will seek hefty discounts on the drug.

Amgen’s next-generation cholesterol drug has shown it can reverse the build up of plaque build-up in coronary arteries which can lead to a heart attack or stroke. The company’s Repatha ...

It’s not known whether Repatha (evolocumab) is safe to use while pregnant or breastfeeding. Certain factors may determine whether you should use the drug during this time. It’s not known ...

The massive pharmacy benefit manager plans to stop requiring coverage reauthorizations for roughly 80 drugs used to treat ...

Amgen’s AMGN stock has risen 21.7% so far this year compared with an increase of 7% for the industry. AMGN Stock Performance ...

The company expects next quarter to read out initial data from its Heart-2 trial, which is testing a one-time treatment for ...

The company has a deep lineup of medicines that includes growth drivers like Repatha, a drug used to decrease the risk of heart attacks in certain patients; asthma therapy Tezspire; Teppezza ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options ...